Bioceres Crop Solutions (NASDAQ:BIOX) Trading 4.5% Higher – Here’s What Happened

Bioceres Crop Solutions Corp. (NASDAQ:BIOX)’s stock price shot up 4.5% during mid-day trading on Wednesday . The stock traded as high as $4.39 and last traded at $4.38. 163,361 shares were traded during mid-day trading, an increase of 5% from the average session volume of 156,314 shares. The stock had previously closed at $4.19.

Analysts Set New Price Targets

BIOX has been the topic of several research reports. Lake Street Capital reduced their price objective on Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating on the stock in a report on Friday, February 7th. Oppenheimer decreased their price objective on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a report on Tuesday, January 28th. Finally, Canaccord Genuity Group lowered their price objective on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating for the company in a research note on Thursday, February 13th. Four investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Bioceres Crop Solutions currently has a consensus rating of “Buy” and an average target price of $9.88.

Bioceres Crop Solutions Price Performance

The firm has a market cap of $307.28 million, a P/E ratio of 245.12 and a beta of 0.73. The company has a current ratio of 1.33, a quick ratio of 0.96 and a debt-to-equity ratio of 0.43. The firm has a 50-day simple moving average of $5.27 and a 200-day simple moving average of $6.42.

Institutional Investors Weigh In On Bioceres Crop Solutions

A number of institutional investors have recently added to or reduced their stakes in the stock. Fourth Sail Capital LP lifted its position in shares of Bioceres Crop Solutions by 16.6% during the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock valued at $22,490,000 after buying an additional 527,859 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Bioceres Crop Solutions by 135.0% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 752,335 shares of the company’s stock worth $4,574,000 after acquiring an additional 432,206 shares in the last quarter. Long Focus Capital Management LLC lifted its position in Bioceres Crop Solutions by 130.7% during the fourth quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company’s stock valued at $4,528,000 after acquiring an additional 421,931 shares during the last quarter. Ballast Asset Management LP lifted its position in Bioceres Crop Solutions by 23.5% during the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock valued at $2,620,000 after acquiring an additional 82,187 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in Bioceres Crop Solutions by 49.3% in the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock valued at $708,000 after acquiring an additional 29,693 shares in the last quarter. Institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.